Sop For Diagnosis Of Top 20 Common Diseases Updated ((full)) Today

Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline

Fasting lipid profile (Total Cholesterol, HDL-C, LDL-C, Triglycerides). Assess secondary causes by checking TSH (hypothyroidism) and hepatic enzymes. 4. Coronary Artery Disease (CAD)

Imaging: Ultrasound showing increased hepatic echogenicity ("bright liver"), acoustic attenuation, and blurring of vascular structures.

Measure and log blood pressure, heart rate, respiratory rate, temperature, and oxygen saturation ( SpO2cap S p cap O sub 2 ) for every patient. sop for diagnosis of top 20 common diseases updated

Polyuria, polydipsia, polyphagia, unexplained weight loss, blurred vision, or recurrent infections. Diagnostic Workup:

Peak expiratory flow rate (PEFR) measurement and SpO2 monitoring.

Ferritin < 30 ng/mL is the most sensitive marker for iron deficiency. 18. Depression / Anxiety unexplained weight loss

Persistent airflow limitation confirmed by post-bronchodilator spirometry. Mandatory Workup: Spirometry showing a post-bronchodilator

Confirm patient identity using at least two identifiers (Full Name and Date of Birth) alongside the medical record number (MRN) before any diagnostic sampling or imaging.

Clinicians must document all confirmed diagnoses utilizing exact ICD-11 tracking codes within the Electronic Health Record (EHR). or recurrent infections.

Structured Clinical Interview and Validated Rating Scales. Confirmatory Matrix: Psychometric Tools: GAD-7 screening score ≥10is greater than or equal to 10 indicates a high probability of GAD.

Microcytic, hypochromic anemia accompanied by depleted iron stores. Diagnostic Protocol: Order a Complete Blood Count (CBC): Note hemoglobin ( in females, in males) and Mean Corpuscular Volume (MCV

Spirometry with Post-Bronchodilator Reversibility Testing. Confirmatory Matrix: Airflow Limitation: ratio below the lower limit of normal (typically Reversibility: Increase in FEV1FEV sub 1 10–15 minutes after inhaling of albuterol/salbutamol. Alternative: Peak Expiratory Flow (PEF) variability over two weeks. 3.6 Chronic Obstructive Pulmonary Disease (COPD)